Search - tctmd.com

Displaying 61 - 80 of 127

Sort: Relevancy | Date

Presentation TCT 2018

Renal Denervation: Light on the Horizon?

Presenter: Jeroen J. Bax, Stephan Windecker, Felix Mahfoud

September 21, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Industry News

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

May 17, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

Presentation TCT 2017

The Potential for Neuromodulation in Heart Failure

Presenter: Felix Mahfoud

November 01, 2017

Presentation TCT 2017

Transcatheter Carotid Body Denervation (Cibiem): First-in-Man Results and Future Directions

Presenter: Elazer R. Edelman, Paul A. Sobotka, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Diagnostic Mapping and Functional Assessment of the Renal Nerves: The Pythagoras Device

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Alcohol-Mediated Renal Denervation With a Higher-Dose: From the European Registry to Target BP 1

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2016

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Presenter: Bernard J. Gersh, Felix Mahfoud, Ori Ben-Yehuda

November 01, 2016

Presentation TCT 2016

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein

November 01, 2016

Presentation TCT 2016

Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control

Presenter: Bernard J. Gersh, Felix Mahfoud

November 01, 2016

Presentation TCT 2016

Editorial Perspective: Interventional Treatment of Hypertension: A Chance for A Second Wind?

Presenter: Felix Mahfoud

October 31, 2016

Presentation TCT 2016

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Felix Mahfoud

October 30, 2016

Presentation TCT 2016

Hypertension Treatment Targets Beyond the Kidneys

Presenter: Felix Mahfoud, Michael A. Weber, Atul Pathak

October 30, 2016

Presentation TCT 2016

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner

October 30, 2016

Presentation TCT 2016

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Presenter: Felix Mahfoud, Michael A. Weber, Ehtisham Mahmud

October 30, 2016

Presentation TCT 2016

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Presenter: Felix Mahfoud, Michael A. Weber

October 30, 2016

News Features

Future of Renal Denervation May Hinge on a Handful of Small Studies

Todd Neale

February 14, 2016

Advertisement

Renal Denervation: Light on the Horizon?

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

The Potential for Neuromodulation in Heart Failure

Transcatheter Carotid Body Denervation (Cibiem): First-in-Man Results and Future Directions

Diagnostic Mapping and Functional Assessment of the Renal Nerves: The Pythagoras Device

Alcohol-Mediated Renal Denervation With a Higher-Dose: From the European Registry to Target BP 1

Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control

Editorial Perspective: Interventional Treatment of Hypertension: A Chance for A Second Wind?

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Hypertension Treatment Targets Beyond the Kidneys

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Future of Renal Denervation May Hinge on a Handful of Small Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content